≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

L04AX Other immunosuppressants

PheWeb

RX_L04AX

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L04AX

21056

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

17373

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

17373

diagram downward connector

Include endpoints None

17373

diagram downward connector
RX_L04AX

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 17373 10823 6550
Unadjusted prevalence (%) 4.88 5.45 4.16
Mean age at first event (years) 50.50 49.50 52.17

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.41 [1.95, 2.98] 4.1e-16 1113
15 years 0.01 1.65 [1.36, 2.00] 3.6e-7 586
5 years 0.00 3.21 [2.70, 3.82] 1.6e-39 349
1 year 0.00 3.47 [2.63, 4.59] 1.7e-18 68

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L04AX – L04AX Other immunosuppressants
GWS hits:

Survival analyses between endpoints

↥

Plot

before L04AX Other immunosuppressants
after L04AX Other immunosuppressants

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L04AX Other immunosuppressants

↥